Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




Home | Contact Us
 Health and Human Services Logo



Animated FirstGov Logo - Click to enter FirstGov


Psittacosis (Chlamydophila psittaci) (Ornithosis)

Contents
Home - National Notifiable Diseases Surveillance System
Overview
Introduction
List of Infectious Nationally Notifiable Condtions
List of Non-Infectious Nationally Notifiable Conditions
Alphabetical List of Case Definitions
Definition of Terms
Related Links
References
  Site Search


2010 Case Definition

CSTE Position Statement Number: 09-ID-13

Clinical description

Psittacosis is an illness characterized by fever, chills, headache, myalgia, and a dry cough with pneumonia often evident on chest x-ray. Severe pneumonia requiring intensive-care support, endocarditis, hepatitis, and neurologic complications occasionally occur.

Laboratory criteria for diagnosis

  • Isolation of Chlamydophila psittaci from respiratory specimens (e.g., sputum, pleural fluid, or tissue), or blood, or
  • Fourfold or greater increase in antibody (Immunoglobulin G [IgG]) against C. psittaci by complement fixation (CF) or microimmunofluorescence (MIF) between paired acute- and convalescent-phase serum specimens obtained at least 2-4 weeks apart , or
  • Supportive serology (e.g. C. psittaci antibody titer [Immunoglobulin M (IgM)] of greater than or equal to 32 in at least one serum specimen obtained after onset of symptoms), or
  • Detection of C. psittaci DNA in a respiratory specimen (e.g. sputum, pleural fluid or tissue) via amplification of a specific target by polymerase chain reaction (PCR) assay.

Case classification

Probable: An illness characterized by fever, chills, headache, cough and myalgia that has either:
  • Supportive serology (e.g. C. psittaci antibody titer [Immunoglobulin M, IgM] of greater than or equal to 32 in at least one serum specimen obtained after onset of symptoms), OR
  • Detection of C. psittaci DNA in a respiratory specimen (e.g. sputum, pleural fluid or tissue) via amplification of a specific target by polymerase chain reaction (PCR) assay.
Confirmed: An illness characterized by fever, chills, headache, cough and myalgia, and laboratory confirmed by either:
  • Isolation of Chlamydophila psittaci from respiratory specimens (e.g., sputum, pleural fluid, or tissue), or blood, OR
  • Fourfold or greater increase in antibody (Immunoglobulin G [IgG]) against C. psittaci by complement fixation (CF) or microimmunofluorescence (MIF) between paired acute- and convalescent-phase serum specimens obtained at least 2-4 weeks apart.

Comment

Although MIF has shown greater specificity to C. psittaci than CF, positive serologic findings by both techniques may occur as a result of infection with other Chlamydia species and should be interpreted with caution. To increase the reliability of test results, acute- and convalescent-phase serum specimens should be analyzed at the same time in the same laboratory. A realtime polymerase chain reaction (rtPCR) has been developed and validated in avian specimens but has not yet been validated for use in humans (1).

References

  1. Mitchell, S.L., Wolff, B.J., Thacker, W.L., Ciembor, P.G., Gregory, C.R., Everett, K.D., Ritchie, B.W., & Winchell, J.M. (2009). Genotyping of Chlamydophila psittaci by real-time PCR and high-resolution melt analysis. J Clin Microbiol, 47(1),175-181.

See also:

Printable Version

 


 



Privacy Policy | Accessibility

Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated November 17, 2011

United States Department of Health and Human Services
Centers for Disease Control and Prevention